Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleRituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease.AuthorsOkamoto, M.; Okano, A.; Akamatsu, S.; Ashihara, E.; Inaba, T.; Takenaka, H.; Katoh, N.; Kishimoto, S.; Shimazaki, C.AbstractA letter to the editor is presented about the effectivity of rituximab for steroid-refractory sclerodermatous chronic graft-versus-host disease.SubjectsLETTERS to the editor; RITUXIMABPublicationLeukemia (08876924), 2006, Vol 20, Issue 1, p172ISSN0887-6924Publication typeLetterDOI10.1038/sj.leu.2403996